Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis Burmester, G., Fiore, S., Hu, C., Fay, J., Lee, E., Genovese, M. J RHEUMATOL PUBL CO. 2018: 1035
View details for Web of Science ID 000438512300204